ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,278, issued on Sept. 23, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).
"Immunomodulators" was invented by Tao Wang (Farmington, Conn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "In accordance with the present disclosure, compounds have been discovered that bind to PD-L1 and are capable of inhibiting the interaction of PD-L1 with PD-1 and CD80. These macrocyclic compounds exhibit in vitro immunomodulatory efficacy thus making them therapeutic candidates for the treatment of various diseases including cancer and infectious diseases."
The patent was filed on March 30, 2021, under Application No. 17/995,196.
*For further information,...